소프트젤 캡슐 시장 보고서 : 동향, 예측 및 경쟁 분석(-2035년)

Softgel Capsules Market

The future of the global softgel capsules market looks promising with opportunities in the pharmaceutical company, nutraceutical company, cosmeceutical company, and contract manufacturing organization markets. The global softgel capsules market is expected to reach an estimated $16.5 billion by 2035 with a CAGR of 7.1% from 2026 to 2035. The major drivers for this market are the rising demand for flavored & odorless medicine formats, the growing demand for innovation in capsule manufacturing technology, and the increasing demand for consumption of vitamins & herbal supplements.

• Lucintel forecasts that, within the type category, gelatin/animal is expected to witness higher growth over the forecast period due to the high bioavailability and cost effective production.
• Within the end use category, pharmaceutical is expected to witness the highest growth due to the rising demand for pharmaceutical drug delivery.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the expanding pharmaceutical manufacturing and healthcare infrastructure.

Emerging Trends in Softgel Capsules Market

The softgel capsules market is undergoing significant transformation driven by advancements in drug delivery technologies, rising consumer health awareness, and increasing demand for convenient dosage forms. The market is evolving beyond traditional pharmaceutical use, with strong penetration in nutraceuticals, dietary supplements, and functional wellness products. Growing preference for plant-based and clean-label formulations, along with innovations in bioavailability enhancement, is reshaping product development strategies. Digital health expansion, aging populations, and preventive healthcare trends are further accelerating demand across major economies.

• Plant Based Softgel Innovation: Plant based softgel innovation is emerging as a major trend due to increasing consumer demand for vegetarian and vegan alternatives to gelatin-based capsules. Manufacturers are developing capsules using materials such as modified starch, carrageenan, and cellulose derivatives to cater to ethical, religious, and dietary preferences. This shift is especially strong in North America and Europe, where clean-label and cruelty-free products are gaining traction. These plant-based formulations also help companies comply with global regulatory standards and expand export opportunities.
• Enhanced Bioavailability Technologies: Enhanced bioavailability technologies are transforming the effectiveness of softgel capsules by improving absorption rates of active ingredients. Companies are adopting lipid-based delivery systems, nano-emulsions, and self-emulsifying drug delivery systems to increase solubility of poorly water-soluble compounds. This trend is particularly important for vitamins, omega-3 fatty acids, and pharmaceutical drugs with low bioavailability. Improved absorption leads to better therapeutic outcomes and reduced dosage requirements. Pharmaceutical and nutraceutical firms are investing heavily in research and development to optimize formulation efficiency. As a result, softgels are becoming a preferred dosage form for advanced drug delivery applications across both prescription and over-the-counter product segments globally.
• Rising Nutraceutical Demand Growth: Rising nutraceutical demand growth is significantly driving the expansion of The softgel capsules market as consumers increasingly focus on preventive healthcare and wellness products. Vitamins, minerals, herbal extracts, and omega-based supplements are commonly delivered through softgel formats due to their ease of swallowing and improved stability. Aging populations and lifestyle-related health issues are further boosting demand in developed economies. In emerging markets, rising disposable incomes and health awareness are accelerating adoption.
• Sustainability and Clean Label Shift: Sustainability and clean label shift is becoming a crucial trend influencing product development and consumer purchasing decisions in The softgel capsules market. Companies are focusing on environmentally friendly production processes, biodegradable materials, and transparent ingredient labeling. Consumers are increasingly avoiding artificial additives and preferring natural, non-GMO, and allergen-free formulations. This has encouraged manufacturers to redesign capsule shells and reduce chemical processing in production. Regulatory pressure in Europe and North America is also accelerating this shift. As sustainability becomes a key competitive factor, companies that invest in eco-friendly manufacturing and clean-label certifications are gaining stronger brand trust and long-term market advantage.
• Advanced Manufacturing Automation Adoption: Advanced manufacturing automation adoption is reshaping the production landscape of softgel capsules by improving efficiency, consistency, and scalability. Manufacturers are integrating robotics, artificial intelligence, and real-time monitoring systems into encapsulation processes to reduce human error and enhance quality control. Automation enables high-speed production while maintaining strict regulatory compliance standards, especially in pharmaceutical manufacturing. It also helps reduce operational costs and improve batch uniformity. This trend is particularly strong in developed markets where labor costs are high and regulatory requirements are stringent. As a result, companies are increasingly investing in smart manufacturing facilities to meet rising global demand efficiently.

These emerging trends are transforming The softgel capsules market into a highly innovative, sustainability-driven, and technology-enabled industry. The shift toward plant-based materials, enhanced bioavailability, and clean-label products is reshaping consumer preferences, while automation and advanced manufacturing are improving production efficiency. Growing nutraceutical demand and health awareness are expanding market applications across regions. Collectively, these developments are intensifying competition and encouraging continuous innovation, positioning softgel capsules as a critical dosage form in both pharmaceutical and wellness industries worldwide.

Recent Developments in the Softgel Capsules Market

The softgel capsules market is witnessing notable recent developments driven by advancements in formulation technologies, rising nutraceutical demand, and increasing pharmaceutical innovation across major global regions. Manufacturers are focusing on improving drug delivery efficiency, enhancing bioavailability, and introducing plant-based alternatives to meet evolving consumer preferences. Expansion of contract manufacturing, regulatory improvements, and investments in automation are further strengthening production capabilities.

• Plant Based Capsule Expansion: Plant based capsule expansion is a major recent development as manufacturers shift from animal derived gelatin to vegan and vegetarian alternatives. Companies are investing in materials such as modified starch, carrageenan, and hydroxypropyl methylcellulose to meet clean label and ethical consumption demands. This development is particularly strong in North America and Europe, where regulatory standards and consumer awareness are high. It is enabling pharmaceutical and nutraceutical companies to expand into new markets while improving product acceptance among diverse dietary groups. Additionally, improved shell stability technologies are making plant based softgels more reliable and commercially competitive in global supply chains.
• Advanced Drug Delivery Systems Adoption: Advanced drug delivery systems adoption is transforming softgel capsules by improving solubility and absorption of poorly bioavailable compounds. Manufacturers are integrating lipid based formulations, nano emulsions, and self emulsifying drug delivery systems to enhance therapeutic effectiveness. This development is particularly important for vitamins, omega 3 fatty acids, and complex pharmaceutical molecules. It is enabling lower dosage requirements while improving patient outcomes and compliance. Pharmaceutical companies are heavily investing in research and development to optimize these systems. As a result, softgels are increasingly preferred for both prescription drugs and nutraceutical products requiring enhanced bioavailability performance.
• Expansion of Nutraceutical Applications: Expansion of nutraceutical applications is significantly boosting softgel capsule demand as consumers prioritize preventive healthcare and wellness solutions. Softgels are widely used for vitamins, minerals, herbal extracts, and omega based supplements due to their stability and ease of ingestion. This development is driven by rising lifestyle related health concerns, aging populations, and growing disposable incomes in emerging economies. Manufacturers are launching targeted formulations for immunity, heart health, and cognitive support. The nutraceutical sector's rapid growth is positioning softgels as a preferred dosage form, expanding their application beyond traditional pharmaceuticals into mainstream consumer health and wellness markets.
• Manufacturing Automation Integration: Manufacturing automation integration is a key recent development improving efficiency and precision in softgel capsule production. Companies are adopting robotics, artificial intelligence, and real time monitoring systems to enhance encapsulation accuracy and reduce operational errors. This development supports large scale production while ensuring consistent quality and regulatory compliance. Automation also reduces production costs and improves throughput, making manufacturing more scalable and efficient. It is especially important in regions with high labor costs and strict pharmaceutical standards. As a result, automated softgel production facilities are becoming increasingly common across global pharmaceutical and nutraceutical manufacturing hubs.
• Strategic Contract Manufacturing Growth: Strategic contract manufacturing growth is reshaping The softgel capsules market as pharmaceutical and nutraceutical companies outsource production to specialized manufacturers. Contract development and manufacturing organizations are expanding capacity to meet rising global demand and reduce production costs for clients. This development enables smaller brands to access advanced technologies and regulatory expertise without investing in infrastructure. It also accelerates time to market for new products. Increasing globalization of supply chains and demand for cost efficient production are driving this trend. Consequently, contract manufacturing partnerships are becoming a critical component of competitive strategy in the softgel capsules industry.

These recent developments are collectively transforming The softgel capsules market into a more technologically advanced, efficient, and consumer focused industry. Innovations in plant based formulations, drug delivery systems, and nutraceutical applications are expanding market reach and product diversity. At the same time, automation and contract manufacturing are improving scalability, cost efficiency, and global supply chain integration. Together, these developments are enhancing product performance, strengthening regulatory compliance, and accelerating innovation cycles, ultimately driving sustained growth and competitiveness across pharmaceutical and nutraceutical sectors worldwide.

Strategic Growth Opportunities in the Softgel Capsules Market

The softgel capsules market is expanding across global healthcare and wellness industries due to rising demand for convenient dosage forms and improved therapeutic delivery. Growth is driven by increasing use in nutraceutical, pharmaceutical, cosmetic, and veterinary applications. Advancements in plant based shells, bioavailability enhancement technologies, and contract manufacturing services are strengthening industry development. Rising health awareness, aging populations, and preventive healthcare adoption are supporting demand. These factors are creating strong opportunities for manufacturers to innovate and expand applications across diverse segments worldwide.

• Nutraceutical Softgel Applications Expansion: Nutraceutical softgel applications expansion is creating significant growth opportunities as consumers increasingly adopt dietary supplements for preventive healthcare and wellness management. Softgels are widely used for vitamins, minerals, omega fatty acids, herbal extracts, and specialty nutrients due to high absorption efficiency and ease of consumption. Rising health awareness and aging populations are driving demand across global markets. Manufacturers are developing advanced formulations with improved stability, taste masking, and enhanced bioavailability. Growth in e commerce and direct to consumer supplement brands is further accelerating adoption. This application segment is becoming a key revenue driver for softgel capsule manufacturers worldwide across global industry ecosystem.
• Pharmaceutical Drug Delivery Innovation: Pharmaceutical drug delivery innovation using softgel capsules is advancing due to the need for improved solubility, controlled release, and enhanced patient compliance. Softgels enable efficient delivery of poorly water soluble drugs through lipid based formulations and self emulsifying systems. This improves therapeutic effectiveness and reduces dosage frequency. Pharmaceutical companies are investing in nanotechnology, encapsulation techniques, and modified release systems to enhance drug performance. Rising prevalence of chronic diseases is increasing demand for effective oral drug delivery solutions. Regulatory support for advanced formulations and growing clinical research activities are further driving innovation and expanding the use of softgels in prescription therapeutics.
• Cosmetic and Personal Care Integration: Cosmetic and personal care integration of softgel capsules is emerging as a key growth opportunity driven by increasing demand for beauty from within products. Softgels are widely used in skincare supplements, hair health formulations, and anti aging nutraceuticals due to high absorption and stability. Consumers are increasingly preferring oral beauty solutions that complement topical applications. Manufacturers are developing advanced formulations containing collagen, biotin, vitamins, and antioxidants. Growth in premium beauty markets and wellness focused lifestyles is further accelerating adoption. E commerce platforms and influencer driven marketing are also supporting expansion. This segment is becoming a contributor to market diversification.
• Veterinary Health Supplement Growth: Veterinary health supplement growth using softgel capsules is expanding due to rising pet ownership and increasing focus on animal health and nutrition. Softgels are widely used for delivering vitamins, fatty acids, and therapeutic supplements to companion animals due to ease of administration and high palatability. Veterinary pharmaceutical companies are investing in advanced formulations to improve absorption and stability. Growth in livestock health management is also contributing to demand. Increasing awareness among pet owners about preventive care is driving adoption. Expansion of veterinary clinics and e commerce distribution channels is further supporting market penetration and product availability globally today globally.
• Functional Food and Wellness Product Expansion: Functional food and wellness product expansion represents a significant opportunity for softgel capsules as consumers increasingly seek convenient and science backed nutrition solutions. Softgels are used to deliver omega fatty acids, vitamins, probiotics, and plant based extracts in functional food supplements. Rising demand for preventive healthcare and lifestyle management is driving adoption across all age groups. Food manufacturers are integrating softgel based supplements into daily nutrition products. Innovation in flavor masking, stability, and bioavailability is enhancing product effectiveness. Growth in retail, e commerce, and health focused brands is further accelerating market penetration across global wellness and nutrition industries today globally.

These growth opportunities across key applications are transforming The softgel capsules market by expanding use in pharmaceuticals, nutraceuticals, cosmetics, veterinary care, and functional foods. Innovation in formulation technologies, bioavailability enhancement, and plant based alternatives is improving product performance and acceptance. Rising health awareness, preventive healthcare trends, and digital distribution channels are accelerating adoption. Investments in manufacturing automation and research are strengthening capabilities. Overall, these developments are creating a diversified, competitive, and innovation driven global market landscape for softgel capsule manufacturers.

Softgel Capsules Market Drivers and Challenges

The softgel capsules market is influenced by a complex mix of technological advancements, economic conditions, and regulatory frameworks shaping global healthcare and nutraceutical industries. Rising demand for convenient dosage forms, improved drug delivery systems, and expanding wellness awareness are key growth enablers. At the same time, stringent regulatory requirements, raw material cost fluctuations, and manufacturing complexities present notable constraints. Innovation in plant based formulations, automation, and bioavailability enhancement continues to reshape product development. These combined forces are creating a dynamic market environment where manufacturers must balance innovation, compliance, and cost efficiency to remain competitive globally across pharmaceutical and nutraceutical sectors.

The factors responsible for driving the softgel capsules market include:-

• Rising Demand for Nutraceutical Products: Rising demand for nutraceutical products is a major driver of The softgel capsules market as consumers increasingly prioritize preventive healthcare and wellness. Softgels are widely used for vitamins, omega fatty acids, minerals, and herbal supplements due to their superior absorption and ease of ingestion. Growing awareness of lifestyle related diseases and aging populations is boosting consumption across developed and emerging economies. Expansion of e commerce platforms and direct to consumer supplement brands is further increasing accessibility. Manufacturers are innovating with advanced formulations targeting immunity, heart health, and cognitive wellness, making nutraceutical applications a key revenue generating segment globally today.
• Advancements in Drug Delivery Technologies: Advancements in drug delivery technologies are significantly driving market growth by improving the effectiveness of pharmaceutical formulations. Softgel capsules enable enhanced solubility and bioavailability for poorly water soluble drugs using lipid based systems and self emulsifying drug delivery technologies. These innovations improve therapeutic outcomes and patient compliance by enabling controlled and sustained release mechanisms. Pharmaceutical companies are investing heavily in research and development to optimize encapsulation processes and formulation stability. The increasing prevalence of chronic diseases such as cardiovascular disorders and diabetes is further accelerating demand for advanced oral drug delivery systems, strengthening softgels role in modern pharmaceutical applications globally today.
• Expansion of Plant Based Formulations: Expansion of plant based formulations is driving market growth as consumers shift toward vegan, vegetarian, and clean label products. Manufacturers are replacing animal derived gelatin with materials such as hydroxypropyl methylcellulose, modified starch, and carrageenan. This transition is particularly strong in North America and Europe, where ethical consumption and regulatory compliance are key priorities. Plant based softgels also enable companies to cater to diverse dietary and religious preferences, expanding their global customer base. Continuous improvements in shell stability and moisture resistance are enhancing product performance. This trend is strengthening market acceptance and opening new opportunities in premium supplement segments worldwide.
• Growth in Contract Manufacturing Services: Growth in contract manufacturing services is accelerating The softgel capsules market by enabling pharmaceutical and nutraceutical companies to outsource production to specialized facilities. Contract development and manufacturing organizations provide cost efficient, scalable, and regulatory compliant production capabilities. This allows smaller companies to launch products without heavy capital investment in infrastructure. It also enables faster time to market for new formulations. Globalization of supply chains and rising demand for customized formulations are further strengthening this trend. Contract manufacturers are expanding capacities and adopting advanced technologies, making them critical partners in meeting growing global demand for softgel based products efficiently.

The challenges facing the softgel capsules market include:

• High Manufacturing Complexity and Cost: High manufacturing complexity and cost represent a significant challenge in The softgel capsules market due to the need for specialized equipment, controlled environments, and precise formulation processes. Producing stable softgels requires strict temperature, humidity, and encapsulation controls, increasing operational expenses. Plant based alternatives further add complexity due to stability and compatibility issues. Smaller manufacturers often struggle with high initial investment and maintenance costs. Additionally, ensuring consistent quality across large production batches demands advanced automation and skilled workforce. These factors collectively increase production costs, limiting entry for new players and creating pricing pressure in competitive global markets.
• Regulatory Compliance Challenges: Regulatory compliance challenges are another key barrier as softgel capsules must meet strict pharmaceutical and nutraceutical standards across different regions. Varying regulations in the United States, Europe, and Asia Pacific require manufacturers to maintain multiple compliance frameworks, increasing operational complexity. Approval processes for new formulations can be time consuming and costly. Additionally, evolving guidelines for clean label ingredients and plant based materials require continuous product reformulation and documentation. Non compliance risks can lead to product recalls and market restrictions. These regulatory burdens slow down innovation cycles and increase time to market for new softgel based products globally today.
• Raw Material Supply Volatility: Raw material supply volatility is a major challenge impacting production stability in The softgel capsules market. Key inputs such as gelatin, plant based polymers, and pharmaceutical grade oils are subject to price fluctuations and supply chain disruptions. Dependence on animal derived materials also creates risks related to disease outbreaks and ethical sourcing concerns. Global logistics disruptions further affect availability and cost structures. Manufacturers often face difficulty in maintaining consistent quality and pricing stability. This volatility impacts profit margins and long term planning, forcing companies to diversify suppliers and invest in alternative raw materials to ensure uninterrupted production continuity globally.

The softgel capsules market is shaped by strong growth drivers such as rising nutraceutical demand, advancements in drug delivery technologies, expansion of plant based formulations, and increasing contract manufacturing services. However, challenges including high manufacturing complexity, stringent regulatory requirements, and raw material volatility continue to create operational pressures. Together, these factors are driving a balanced yet competitive market environment.

List of Softgel Capsules Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies softgel capsules market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the softgel capsules market companies profiled in this report include-

• Fuji Capsules
• Sirio Pharma
• Captek
• Patheon
• Catalent
• Eurocaps
• Aenova
• Capsugel
• Procaps Laboratories
• Soft Gel Technologies

Softgel Capsules Market by Segment

The study includes a forecast for the global softgel capsules market by type, product type, technology, end use, and region.

Softgel Capsules Market by Type [Value ($B) from 2019 to 2035]:

• Gelatin/Animal
• Non-Animal

Softgel Capsules Market by Product Type [Value ($B) from 2019 to 2035]:

• Prescription Medicine
• Health & Dairy Supplements

Softgel Capsules Market by Technology [Value ($B) from 2019 to 2035]:

• Antacid & Anti-Flatulent Preparation
• Anti-Anemic Preparations
• Anti-Inflammatory Drugs
• Antibiotic & Antibacterial Drugs
• Cough & Cold Preparations
• Health Supplement
• Vitamin & Dietary Supplement
• Pregnancy

Softgel Capsules Market by End Use [Value ($B) from 2019 to 2035]:

• Pharmaceutical Companies
• Nutraceutical Companies
• Cosmeceutical Companies
• Contract Manufacturing Organizations

Softgel Capsules Market by Region [Value ($B) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Softgel Capsules Market

The softgel capsules market is witnessing steady expansion globally, driven by rising demand for easy-to-swallow dosage forms, increasing use in nutraceuticals and pharmaceuticals, and rapid innovations in plant-based and high-bioavailability formulations. Recent developments are strongly influenced by aging populations, preventive healthcare trends, and growing consumer preference for dietary supplements. Technological advancements such as vegan soft gel shells, delayed-release systems, and nano-encapsulation are reshaping product innovation. At the same time, countries such as the United States, China, Germany, India, and Japan are experiencing region-specific developments driven by manufacturing capabilities, regulatory evolution, and increasing health awareness, making the global market more competitive and innovation-focused.

• United States: The softgel capsules market is experiencing strong innovation driven by rising demand for dietary supplements and prescription drug delivery systems. Companies are increasingly focusing on plant-based and clean-label soft gels, especially for omega-3, vitamins, and specialty therapeutics. Growth in e-commerce and direct-to-consumer supplement brands is accelerating product accessibility. Pharmaceutical firms are also investing in advanced delivery technologies such as delayed-release and enhanced bioavailability soft gels.
• China: China's softgel capsules market is expanding rapidly due to its strong pharmaceutical manufacturing base and large-scale production capabilities. Recent developments include increased investment in automation, advanced encapsulation technologies, and integration of Traditional Chinese Medicine formulations into soft gel formats. The country is also witnessing rising adoption of plant-based and gelatin-free capsules to meet global export standards. Strong government support for healthcare innovation and growing domestic demand from an aging population are further driving market growth.
• Germany: Germany is emerging as a key European hub for high-quality and regulated soft gel capsule production, supported by its advanced pharmaceutical industry and strict compliance standards. Recent developments include increased adoption of vegan and non-animal softgel technologies to meet rising consumer demand for clean-label supplements. German manufacturers are focusing on high-precision formulation technologies, particularly for cardiovascular, hormonal, and neurological therapies. The country is also experiencing strong demand for nutraceutical softgels such as omega-3 and vitamin-based supplements.
• India: India's softgel capsules market is growing rapidly due to expanding pharmaceutical manufacturing, rising nutraceutical consumption, and strong export-oriented production. Recent developments include increased investment in capsule filling facilities and contract manufacturing organizations supporting global demand. Indian companies are focusing on cost-effective production of gelatin and non-gelatin softgels, particularly for vitamins, herbal extracts, and omega-based supplements. Government initiatives supporting domestic manufacturing and healthcare access are also boosting growth.
• Japan: Japan's softgel capsules market is evolving steadily, driven by its aging population and high demand for precision nutrition and pharmaceutical delivery systems. Recent developments include growing use of softgels in anti-aging, eye health, and cognitive health supplements. Japanese manufacturers are focusing on high-quality, small-dose, and highly stable formulations to meet strict regulatory standards. There is also increasing adoption of advanced encapsulation technologies for combining multiple functional ingredients in a single dosage form.

Features of the Global Softgel Capsules Market

• Market Size Estimates: Softgel capsules market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
• Segmentation Analysis: softgel capsules market size by various segments, such as by type, product type, technology, end use, and region in terms of value ($B).
• Regional Analysis: Softgel capsules market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different type, product type, technology, end use, and regions for the softgel capsules market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the softgel capsules market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the softgel capsules market by type (gelatin/animal and non-animal), product type (prescription medicine and health & dairy supplements), technology (antacid & anti-flatulent preparation, anti-anemic preparations, anti-inflammatory drugs, antibiotic & antibacterial drugs, cough & cold preparations, health supplement, vitamin & dietary supplement, and pregnancy), end use (pharmaceutical companies, nutraceutical companies, cosmeceutical companies, and contract manufacturing organizations), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Softgel Capsules Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Gelatin/Animal : Trends and Forecast (2019 to 2035)
• 4.4 Non-Animal : Trends and Forecast (2019 to 2035)

5. Global Softgel Capsules Market by Product Type

• 5.1 Overview
• 5.2 Attractiveness Analysis by Product Type
• 5.3 Prescription Medicine : Trends and Forecast (2019 to 2035)
• 5.4 Health & Dairy Supplements : Trends and Forecast (2019 to 2035)

6. Global Softgel Capsules Market by Technology

• 6.1 Overview
• 6.2 Attractiveness Analysis by Technology
• 6.3 Antacid & Anti-Flatulent Preparation : Trends and Forecast (2019 to 2035)
• 6.4 Anti-Anemic Preparations : Trends and Forecast (2019 to 2035)
• 6.5 Anti-Inflammatory Drugs : Trends and Forecast (2019 to 2035)
• 6.6 Antibiotic & Antibacterial Drugs : Trends and Forecast (2019 to 2035)
• 6.7 Cough & Cold Preparations : Trends and Forecast (2019 to 2035)
• 6.8 Health Supplement : Trends and Forecast (2019 to 2035)
• 6.9 Vitamin & Dietary Supplement : Trends and Forecast (2019 to 2035)
• 6.10 Pregnancy : Trends and Forecast (2019 to 2035)

7. Global Softgel Capsules Market by End Use

• 7.1 Overview
• 7.2 Attractiveness Analysis by End Use
• 7.3 Pharmaceutical Companies : Trends and Forecast (2019 to 2035)
• 7.4 Nutraceutical Companies : Trends and Forecast (2019 to 2035)
• 7.5 Cosmeceutical Companies : Trends and Forecast (2019 to 2035)
• 7.6 Contract Manufacturing Organizations : Trends and Forecast (2019 to 2035)

8. Regional Analysis

• 8.1 Overview
• 8.2 Global Softgel Capsules Market by Region

9. North American Softgel Capsules Market

• 9.1 Overview
• 9.2 North American Softgel Capsules Market by Type
• 9.3 North American Softgel Capsules Market by End Use
• 9.4 The United States Softgel Capsules Market
• 9.5 Canadian Softgel Capsules Market
• 9.6 Mexican Softgel Capsules Market

10. European Softgel Capsules Market

• 10.1 Overview
• 10.2 European Softgel Capsules Market by Type
• 10.3 European Softgel Capsules Market by End Use
• 10.4 German Softgel Capsules Market
• 10.5 French Softgel Capsules Market
• 10.6 Italian Softgel Capsules Market
• 10.7 Spanish Softgel Capsules Market
• 10.8 The United Kingdom Softgel Capsules Market

11. APAC Softgel Capsules Market

• 11.1 Overview
• 11.2 APAC Softgel Capsules Market by Type
• 11.3 APAC Softgel Capsules Market by End Use
• 11.4 Chinese Softgel Capsules Market
• 11.5 Indian Softgel Capsules Market
• 11.6 Japanese Softgel Capsules Market
• 11.7 South Korean Softgel Capsules Market
• 11.8 Indonesian Softgel Capsules Market

12. ROW Softgel Capsules Market

• 12.1 Overview
• 12.2 ROW Softgel Capsules Market by Type
• 12.3 ROW Softgel Capsules Market by End Use
• 12.4 Middle Eastern Softgel Capsules Market
• 12.5 South American Softgel Capsules Market
• 12.6 African Softgel Capsules Market

13. Competitor Analysis

• 13.1 Product Portfolio Analysis
• 13.2 Operational Integration
• 13.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 13.4 Market Share Analysis

14. Opportunities & Strategic Analysis

• 14.1 Value Chain Analysis
• 14.2 Growth Opportunity Analysis
  • 14.2.1 Growth Opportunity by Type
  • 14.2.2 Growth Opportunity by Product Type
  • 14.2.3 Growth Opportunity by Technology
  • 14.2.4 Growth Opportunity by End Use
  • 14.2.5 Growth Opportunity by Region
• 14.3 Emerging Trends in the Global Softgel Capsules Market
• 14.4 Strategic Analysis
  • 14.4.1 New Product Development
  • 14.4.2 Certification and Licensing
  • 14.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

15. Company Profiles of the Leading Players Across the Value Chain

• 15.1 Competitive Analysis Overview
• 15.2 Fuji Capsules
  • Company Overview
  • Softgel Capsules Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.3 Sirio Pharma
  • Company Overview
  • Softgel Capsules Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.4 Captek
  • Company Overview
  • Softgel Capsules Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.5 Patheon
  • Company Overview
  • Softgel Capsules Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.6 Catalent
  • Company Overview
  • Softgel Capsules Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.7 Eurocaps
  • Company Overview
  • Softgel Capsules Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.8 Aenova
  • Company Overview
  • Softgel Capsules Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.9 Capsugel
  • Company Overview
  • Softgel Capsules Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.10 Procaps Laboratories
  • Company Overview
  • Softgel Capsules Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 15.11 Soft Gel Technologies
  • Company Overview
  • Softgel Capsules Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

16. Appendix

• 16.1 List of Figures
• 16.2 List of Tables
• 16.3 Research Methodology
• 16.4 Disclaimer
• 16.5 Copyright
• 16.6 Abbreviations and Technical Units
• 16.7 About Us
• 16.8 Contact Us